Cellebrite officer plans sale of 4,323 shares

Cellebrite DI Ltd. (CLBT) is the issuer of common stock that David Gee, identified as an officer, plans to sell under Rule 144.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) is the issuer of common stock that David Gee, identified as an officer, plans to sell under Rule 144. The notice covers a proposed sale of 4,323 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated aggregate market value of $47,769.15 as of August 24, 2026. The securities to be sold arise from Restricted Stock Units from the issuer. The filing also lists prior sales by David Gee over the past three months.

Key Figures

Shares to be sold: 4,323 shares Aggregate market value of shares to be sold: $47,769.15 Shares sold on August 21, 2026: 2,198 shares +3 more

6 metrics

Shares to be sold 4,323 shares Common stock covered by the Form 144 notice

Aggregate market value of shares to be sold $47,769.15 Value of 4,323 CLBT shares as listed for the planned sale

Shares sold on August 21, 2026 2,198 shares Common stock sold by David Gee during the past 3 months

Proceeds on August 21, 2026 sale $24,709.04 Value of 2,198 CLBT shares sold by David Gee

Shares sold on August 11, 2026 230 shares Common stock sold by David Gee during the past 3 months

Proceeds on August 11, 2026 sale $3,686.90 Value of 230 CLBT shares sold by David Gee

Key Terms

Form 144, Rule 144, Restricted Stock Units

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 08/20/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CLBT by David Gee disclose?

It discloses that David Gee, an officer of Cellebrite DI Ltd. (CLBT), has filed a Form 144 to sell 4,323 shares of the company’s common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

How many CLBT shares does David Gee plan to sell under this Form 144?

David Gee plans to sell 4,323 shares of Cellebrite DI Ltd. common stock. The filing lists these shares in the securities information and securities-to-be-sold sections, tied to Restricted Stock Units from the issuer.

What is the aggregate market value of the CLBT shares to be sold by David Gee?

The aggregate market value of the 4,323 CLBT shares covered by the notice is listed as $47,769.15 as of August 24, 2026, in the securities information section of the filing.

What prior CLBT stock sales by David Gee are reported in the last 3 months?

The filing reports that David Gee sold 2,198 shares of CLBT common stock on August 21, 2026 for $24,709.04, and 230 shares on August 11, 2026 for $3,686.90, in the securities sold during the past 3 months section.

What type of securities is David Gee selling from Cellebrite DI Ltd. (CLBT)?

David Gee is selling common stock of Cellebrite DI Ltd. The securities to be sold are linked to Restricted Stock Units from the issuer, as specified in the securities-to-be-sold section of the Form 144 notice.

Through which broker will the CLBT shares under this Form 144 be sold?

The Form 144 indicates that the CLBT common shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading to occur on NASDAQ, as listed in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:31 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:29 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001547134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 Shlomo Shmelzer Road Petah Tikva ISRAEL 4970602
Phone	972733948000
Name of Person for Whose Account the Securities are To Be Sold	DAVID GEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4323	47769.15	250785933	08/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2026	Restricted Stock Units	Issuer			4323	08/20/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID GEE 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/21/2026	2198	24709.04
DAVID GEE 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/11/2026	230	3686.90

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Gee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)